Inhibition of protein synthesis by didemnins: Cell potency and SAR

Journal of Medicinal Chemistry

Volumn 43, Issue 22, 2000, Pages 4212-4218

  Ahuja, D ^a   Geiger, A ^a   Ramanjulu, J M ^b   Vera, M D ^b   SirDeshpande, B ^a   Pfizenmayer, A ^a   Abazeed, M ^c   Krosky, D J ^a   Beidler, D ^c   Joullie M M ^b   Toogood, P L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDEMNIN DERIVATIVE; LEUCINE; N METHYLALANINE; N METHYLLEUCINE; N,O DIMETHYLTYROSINE; PROTEIN SYNTHESIS INHIBITOR; TAMANDARIN A; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC 50; NONHUMAN; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RABBIT; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANIMALS; CELL-FREE SYSTEM; DEPSIPEPTIDES; HUMANS; PEPTIDE ELONGATION FACTOR 1; PEPTIDES, CYCLIC; PROTEIN SYNTHESIS INHIBITORS; RABBITS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034597581     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm000168v     Document Type: Article

References (61)

1. Inhibitors of protein synthesis
2. Recent developments with oxazolidinone antibiotics
3. Intracellular messengers and the control of protein synthesis
4. The didemnins
5. Didemnins: Antiviral and antitumor peptides from a Caribbean tunicate
6. Antitumor activity of didemnin B in the human tumor stem cell assay
7. Mechanism of action of didemnin B, a depsipeptide from the sea
8. Didemnin B induces cell death by apoptosis - The fastest induction of apoptosis ever described
9. Unspecific activation of caspases during the induction of apoptosis by didemnin B in human cell lines
10. Biochemical and cellular effects of didemnins A and B
11. Antiviral and antitumor compounds from tunicates
12. Inhibition of protein synthesis by didemnin b is not sufficient to induce apoptosis in human mammary carcinoma (MCF7) cells
13. GTP-dependent binding of the antiproliferative agent didemnin to elongation factor 1α
14. Mechanism of protein synthesis inhibition by didemnin B in vitro
15. Inhibition of protein synthesis by didemnin B: How EF-1α mediates inhibition of translocation
16. Antiproliferative effect of dehydrodidemnin B (DDB), a depsipeptide isolated from Mediterranean tunicates
17. Inhibition of T-lyphocyte proliferation by the cyclic polypeptide didemnin B: No inhibition of lymphokine stimulation
18. A specific binding site in Nb2 node lymphoma cells mediates the effects of didemnin b, an immunosuppressive cyclic peptide
19. 1 cells: Inhibition of phosphoinositide metabolism and cell proliferation
20. The complete spectral assignment of didemnin H, a new constituent of the tunicate trididemnin cyanophorum
21. Didemnin binds to the palmitoyl thioesterase responsible for infantile neuronal ceroid lipofuscinosis
22. Structure - Activity relationships of the didemnins
23. Structure - Activity relationships in fusidic acid-type antibiotics
24. The mechanism by which cycloheximide and related glutarimide antibiotics inhibit peptide synthesis on reticulocyte ribosomes
25. Actions of aurintricarboxylate, kasugamycin and pactamycin on Escherichia coli polysomes
26. Mode of action of berninamycin. An inhibitor of protein biosynthesis
27. Biphasic modulation by ACTH - Like peptides of protein synthesis in a cell-free system from rat brain
28. The inhibition of protein synthesis in Locusta migratoria by adipokinetic hormone
29. New class of antifungal agents: Jasplakinolide, a cyclodepsipeptide from the marine sponge, jaspis species
30. Jaspamide, a modified peptide from a jaspis sponge, with insecticidal and antifungal activity
31. Jaspaklinolide, a cyclodepsipeptide from the marine sponge jaspis sp.
32. Crystal and molecular structure of destruxin B
33. Jasplakinolide, a cytotoxic natural product, induces actin polymerization and competitively inhibits the binding of phalloidin to F-actin
34. Eledoisin and ceruletide, two naturally occurring peptide drugs of nonmammalian origin
35. Discovery of new antitumor agents from Asian medicinal plants
36. Inhibition of protein synthesis by RA-VII
37. Tamandarins A and B: New cytotoxic depsipeptides from a Brazilian ascidian of the family didemnidae
38. Synthesis of the cyclodepsipeptide nordidemnin B, a cytotoxic minor product isolated from the sea tunicate trididemnun cyanophorum
39. Antineoplastic activity of didemin congeners: Nordidemnin and modified chain analogues
40. 5]-didemnin B
41. Synthesis and biological activity of [Tic5] didemnin B
42. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs
43. Comparison of the manifestation of radiation-induced lethal damage in in vitro and in vivo systems
44. Changes in activity and amount of active elongation factor 1α in aging and immortal human fibroblast cultures
45. Tumor-related expression of a translation-elongation factor-like protein
46. Rat elongation factor 1α: Sequence of cDNA from a highly metastatic fos-transformed cell line
47. Elongation factor-1α gene determines suceptibility to transformation
48. Candidate metastisis-associated genes of the rat 13762NF mammary adenocarcinoma
49. Tissue-dependent variation in the expression of elongation factor-1α isoforms: Isolation and characterization of a cDNA encoding a novel variant of human elongation-factor 1α
50. Elongation factor-1α mRNA is selectively translated following mitogenic stimulation
51. Multiple pathways are involved in protection of MCF-7 cells against death due to protein synthesis inhibition
52. Synthesis of new didemnin B analogues for investigations of structure/biological activity relationships
53. Analogues of the β-turn of the cyclodepsipeptide didemnin B
54. Syntheses of acyclic analogues of didemnin B
55. Synthesis of a reduced ring analogue of didemnin B